# Prostate Cancer Diagnosis and Treatment

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers encompasses a wide range of research on prostate cancer, including screening methods, treatment options such as radiation therapy and surgery, use of MRI imaging for detection, genetic factors, and clinical guidelines for management. The papers also cover topics like Gleason grading, androgen suppression, biopsy techniques, and long-term survival rates. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10124 |
| Works | 459 |

## Topic papers all

Showing 15 of 459.

- [Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer](https://scholariq.org/papers/docetaxel-plus-prednisone-or-mitoxantrone-plus-prednisone-for-advanced-prostate/)
- [Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy](https://scholariq.org/papers/increased-survival-with-enzalutamide-in-prostate-cancer-after-chemotherapy/)
- [Abiraterone and Increased Survival in Metastatic Prostate Cancer](https://scholariq.org/papers/abiraterone-and-increased-survival-in-metastatic-prostate-cancer/)
- [Screening and Prostate-Cancer Mortality in a Randomized European Study](https://scholariq.org/papers/screening-and-prostate-cancer-mortality-in-a-randomized-european-study/)
- [Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer](https://scholariq.org/papers/docetaxel-and-estramustine-compared-with-mitoxantrone-and-prednisone-for/)
- [The American Urological Association Symptom Index for Benign Prostatic Hyperplasia](https://scholariq.org/papers/the-american-urological-association-symptom-index-for-benign-prostatic-2/)
- [Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial](https://scholariq.org/papers/prednisone-plus-cabazitaxel-or-mitoxantrone-for-metastatic-castration-resistant/)
- [The Molecular Taxonomy of Primary Prostate Cancer](https://scholariq.org/papers/the-molecular-taxonomy-of-primary-prostate-cancer/)
- [MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis](https://scholariq.org/papers/mri-targeted-or-standard-biopsy-for-prostate-cancer-diagnosis/)
- [Enzalutamide in Metastatic Prostate Cancer before Chemotherapy](https://scholariq.org/papers/enzalutamide-in-metastatic-prostate-cancer-before-chemotherapy/)
- [Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer](https://scholariq.org/papers/chemohormonal-therapy-in-metastatic-hormone-sensitive-prostate-cancer/)
- [Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy](https://scholariq.org/papers/abiraterone-in-metastatic-prostate-cancer-without-previous-chemotherapy/)
- [Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference](https://scholariq.org/papers/defining-biochemical-failure-following-radiotherapy-with-or-without-hormonal/)
- [AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer](https://scholariq.org/papers/ar-v7-and-resistance-to-enzalutamide-and-abiraterone-in-prostate-cancer/)
- [10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer](https://scholariq.org/papers/10-year-outcomes-after-monitoring-surgery-or-radiotherapy-for-localized-prostate/)

## Topic primary papers

Showing 15 of 204.

- [Screening and Prostate-Cancer Mortality in a Randomized European Study](https://scholariq.org/papers/screening-and-prostate-cancer-mortality-in-a-randomized-european-study/)
- [MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis](https://scholariq.org/papers/mri-targeted-or-standard-biopsy-for-prostate-cancer-diagnosis/)
- [Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference](https://scholariq.org/papers/defining-biochemical-failure-following-radiotherapy-with-or-without-hormonal/)
- [10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer](https://scholariq.org/papers/10-year-outcomes-after-monitoring-surgery-or-radiotherapy-for-localized-prostate/)
- [Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study](https://scholariq.org/papers/prostate-specific-membrane-antigen-pet-ct-in-patients-with-high-risk-prostate/)
- [Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer](https://scholariq.org/papers/radical-prostatectomy-versus-watchful-waiting-in-early-prostate-cancer/)
- [Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up](https://scholariq.org/papers/screening-and-prostate-cancer-mortality-results-of-the-european-randomised-study/)
- [Screening for Prostate Cancer](https://scholariq.org/papers/screening-for-prostate-cancer/)
- [A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score](https://scholariq.org/papers/a-contemporary-prostate-cancer-grading-system-a-validated-alternative-to-the/)
- [Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer](https://scholariq.org/papers/patient-reported-outcomes-after-monitoring-surgery-or-radiotherapy-for-prostate/)
- [Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy](https://scholariq.org/papers/systematic-review-and-meta-analysis-of-studies-reporting-urinary-continence/)
- [Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial](https://scholariq.org/papers/radiotherapy-to-the-primary-tumour-for-newly-diagnosed-metastatic-prostate/)
- [A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer](https://scholariq.org/papers/a-preoperative-nomogram-for-disease-recurrence-following-radical-prostatectomy/)
- [Prostate-Cancer Mortality at 11 Years of Follow-up](https://scholariq.org/papers/prostate-cancer-mortality-at-11-years-of-follow-up/)
- [Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer](https://scholariq.org/papers/urinary-and-sexual-function-after-radical-prostatectomy-for-clinically-localized/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.